Payer Evidence Synthesis & HTA Builder
Build evidence-based health technology assessments for payer coverage decisions
What You Can Do
You can structure comprehensive health technology assessments (HTAs) that organize clinical evidence, economic analyses, and regulatory considerations into evidence-based coverage recommendations. This skill helps you synthesize clinical trial data, health economic models, and real-world evidence into clear, defensible payer coverage determinations. You'll generate professional HTA reports that align with major frameworks like ICER, CADTH, and NICE standards.
Features
Organize clinical evidence from trials, observational studies, and meta-analyses into structured summaries with quality assessments and bias evaluation
Build cost-effectiveness models including cost-benefit analysis, budget impact modeling, and cost per QALY calculations with transparent assumptions
Visualize patient treatment pathways and comparators to identify clinical alternatives and positioning within the therapeutic landscape
Structure quantitative and qualitative assessment of therapeutic benefits against safety signals and adverse event data
Cross-reference coverage decisions with FDA approvals, clinical guideline recommendations, and payer-specific policy criteria
Evaluate implications for patients, providers, manufacturers, and plan finances to anticipate coverage challenges
Export professional HTA documents with executive summaries, evidence tables, economic models, and coverage recommendation justifications
Example Output
Example 1: Evidence Summary Table
| Study | Population | Intervention | Comparator | Primary Outcome | Effect Size | Quality |
|---|---|---|---|---|---|---|
| TRIAL-X | N=500, Stage IIIB NSCLC | Drug A + Chemo | Chemo alone | PFS improvement | 4.2 months (HR 0.68) | High |
| TRIAL-Y | N=400, Same indication | Drug B + Chemo | Chemo alone | OS improvement | 7.1 months (HR 0.71) | High |
Example 2: Cost-Effectiveness Model
Base Case (5-year horizon):
- Intervention cost: $285,000
- Comparator cost: $145,000
- Incremental cost: $140,000
- Life-years gained: 0.8
- QALYs gained: 0.65
- Cost per QALY: $215,385 (vs. $150,000 willingness-to-pay threshold)
- Coverage recommendation: Conditional coverage pending value negotiation
Example 3: Coverage Decision Memo Snippet
Recommendation: Approve with prior authorization for [Indication]
- Clinical justification: Statistically significant PFS/OS benefit across subgroups
- Economic justification: Cost-effectiveness acceptable if negotiated to <$150/QALY
- Restriction: Requires oncologist confirmation of Stage IIIB+ disease
- Annual review: Reassess if real-world uptake or safety signals emerge
What's Included
- HTA Template Library: Pre-built templates for drugs, devices, and diagnostics aligned with ICER, CADTH, and NICE methodologies
- Economic Analysis Workbook: Structured models for cost-effectiveness, budget impact, and sensitivity analysis with built-in validation logic
- Evidence Extraction Framework: Systematic processes for identifying bias, extracting data from publications, and creating quality-scored evidence summaries
- Coverage Decision Logic: Decision trees and criteria matrices that map clinical and economic findings to coverage recommendations and restrictions
- Regulatory Cross-Reference Guide: Alignment checklist with FDA approvals, clinical practice guidelines, and major payer policies
- Professional Report Generator: Formats analysis into executive summary, clinical evidence section, economic model detail, and recommendations with justifications
Who It's For
- Payer Medical Directors and P&T Committee Leaders
- Health Economists and Pharmacoeconomics Analysts
- Clinical Pharmacists and Pharmacy & Therapeutics Specialists
- Coverage Policy Managers and Reimbursement Specialists
- Manufacturer HEOR (Health Economics & Outcomes Research) Teams
Best For
- Evaluating new drug or device coverage requests with clinical and economic justification
- Building health economic models and conducting value-based price negotiations
- Creating evidence-based formulary restrictions and prior authorization criteria
- Conducting comparative effectiveness analysis across therapeutic alternatives
- Preparing formal HTA submissions for regulatory or payer review
You might also like
This skill guides you through rigorous experiment design from hypothesis to analysis plan. You'll compute the statistical power needed for your tests, identify confounding variables to control for, design optimal randomization strategies, and generate pre-registered analysis plans that prevent p-hacking and publication bias. Whether you're running a product A/B test or investigating causal effects in observational data, you get structured, validated designs that account for real-world constraints.
by moonwell-fi
You can build production-grade vector search systems that retrieve semantically similar documents in sub-millisecond time using AgentDB's optimized HNSW indexing. The skill enables you to implement RAG pipelines, semantic search engines, and intelligent knowledge bases with configurable embedding dimensions, distance metrics (cosine, Euclidean, dot product), and similarity thresholds—all with built-in quantization and caching for massive performance gains.
by moonwell-fi
This skill transforms high-level feature requests into actionable implementation plans by conducting deep requirement interviews, analyzing existing codebases (or planning greenfield projects), and producing comprehensive handoff documents. It distinguishes between brownfield development (with existing code to integrate) and greenfield projects (starting from scratch), ensuring your technical strategy accounts for your actual constraints and patterns.
by moonwell-fi
Diagnose root causes of model performance failures, select optimal evaluation metrics based on your use case and data characteristics, and design comprehensive evaluation strategies. You'll get systematic workflows for analyzing failure modes, statistical significance testing, threshold optimization, and cross-validation planning—turning vague model problems into actionable fixes.
by moonwell-fi
This skill helps you systematically diagnose failures in distributed ML training and serving infrastructure. You provide system logs, metrics, and error traces, and Claude performs structured root-cause analysis to identify the underlying issue—whether it's resource exhaustion, distributed system deadlock, data pipeline corruption, or model serving misconfiguration. You get a detailed diagnosis with remediation steps ranked by likelihood and implementation effort.
by moonwell-fi
Systematically evaluate your Claude prompts using quantitative scoring frameworks to identify weaknesses in clarity, task alignment, and output quality. You'll receive detailed optimization recommendations with A/B testing guidance to improve prompt effectiveness and consistency across different use cases and input variations.
by moonwell-fi
You can rapidly compile, organize, and format disparate health economic evidence—from clinical trials to cost-effectiveness analyses—into structured, regulatory-compliant dossiers. This skill maps your evidence to specific payer and HTA requirements, automatically generates evidence hierarchies, and produces submission-ready dossier outlines with formatting that meets regulatory standards for NICE, EUnetHTA, and other major bodies.
by moonwell-fi
You can confidently navigate complex statistical analyses by working through structured workflows that match your research question and data type to the right test. The skill guides you through assumption validation, helps you interpret results accurately without common pitfalls, and walks you through regression diagnostics with full transparency about what your findings actually mean.
by moonwell-fi